Akademiska sjukhuset
Uppsala, Sweden
11 recruiting
Showing 1–11 of 11 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Phase 2Phase 3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb470 enrolled277 locationsNCT07076121
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Not Applicable
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Breast CancerProstate CancerNeoadjuvant Therapy+2 more
Mälardalen University172 enrolled2 locationsNCT06719206
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Celgene960 enrolled279 locationsNCT06764485
Recruiting
Phase 3
RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
Atrial Fibrillation (AF)
Region Stockholm1,600 enrolled7 locationsNCT07187570
Recruiting
Phase 3
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
Colorectal, CancerPeritoneal Metastases
Uppsala University213 enrolled5 locationsNCT04861558
Recruiting
Phase 3
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Karolinska Institutet750 enrolled32 locationsNCT03903835
Recruiting
Phase 3
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Esophageal Squamous Cell Carcinoma
Karolinska University Hospital1,020 enrolled12 locationsNCT04460352
Recruiting
Not Applicable
A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
Malignant Melanoma
Uppsala University1,300 enrolled20 locationsNCT03116412
Recruiting
Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma
Myeloma, Multiple
Uppsala University100 enrolled1 locationNCT06245629